🇺🇸 FDA
Pipeline program

1 TachoSil hemostatic sponge (9,5 cm x 4,8 cm) placed on each side on the external iliac artery.

EC/2013/472

Approved small_molecule completed

Quick answer

1 TachoSil hemostatic sponge (9,5 cm x 4,8 cm) placed on each side on the external iliac artery. for Prostate or Bladder Cancer is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Prostate or Bladder Cancer
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials